Penn State TXT2Quit Study

NACompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Nicotine Dependence, Cigarettes
Interventions
BEHAVIORAL

Motivational Text Messages

Usual care plus motivational text messages sent via Mobile Phone. All participants receive the active medication, Varenicline.

BEHAVIORAL

Control

Usual Care. All participants receive the active medication, Varenicline.

Trial Locations (1)

17033

Penn State Milton S. Hershey Medical Center, Hershey

All Listed Sponsors
lead

Milton S. Hershey Medical Center

OTHER

NCT02367391 - Penn State TXT2Quit Study | Biotech Hunter | Biotech Hunter